New perspectives on pathogenesis and treatment of rejection in kidney transplantation.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003601:Cytotoxicity Tests, Immunologic; D003864:Depression, Chemical; D006084:Graft Rejection / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D010567:Pertussis Vaccine / Q000494:pharmacology; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D014184:Transplantation, Homologous; D014481:United States
D000305:Adrenal Cortex Hormones; D000961:Antilymphocyte Serum; D010567:Pertussis Vaccine; D003520:Cyclophosphamide; D011239:Prednisolone; D001379:Azathioprine; D011241:Prednisone